MBX
MBX Biosciences
MBX
MBX
63 hedge funds and large institutions have $606M invested in MBX Biosciences in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less capital invested
Capital invested by funds: $783M → $606M (-$177M)
Holders
63
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$13.4M | |
| 2 | +$11.4M | |
| 3 | +$11.1M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.49M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$3.13M |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.49M | |
| 3 | -$1.3M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$1.3M |
| 5 |
SC
Stempoint Capital
New York
|
-$1.3M |